Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

Completed · Phase 3

Conditions studied: Sarcoma, Kaposi, HIV Infections

In brief

The purpose of this study is to see if it is safe and effective to use IM862 to treat Kaposi's sarcoma (KS) in AIDS patients.

Key facts

Study ID

NCT00002445

Run by

Cytran

People needed

200

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible for this study if they:
• Are HIV-positive.
• Have AIDS-related Kaposi's sarcoma.
• Have at least 5 skin or mouth sores that do not require chemotherapy.
• Have been taking anti-HIV drugs for at least 8 weeks before study entry with no changes in the regimen.
• Are at least 18 years old.
• Agree to practice effective methods of birth control.

You may not qualify if…

• Patients will not be eligible for this study if they:
• Have an AIDS-related opportunistic infection (except for genital herpes) within 2 weeks of study entry.
• Have had another type of cancer within the past 2 years (except for certain types of skin cancer, cervical cancer, or anal cancer).
• Have a severe chest cold.
• Have certain other serious medical conditions.
• Have received certain medications, including chemotherapy, within the past 4 weeks.
• Abuse alcohol or drugs.
• Are pregnant or breast-feeding.

Where it is running

• AIDS Healthcare Foundation — Los Angeles, California, United States
• LAGLC — Los Angeles, California, United States
• USC School of Medicine / Norris Cancer Hosp — Los Angeles, California, United States
• Tower ID Med Associates — Los Angeles, California, United States
• UCLA Care Ctr — Los Angeles, California, United States
• UCSD Med Ctr — San Diego, California, United States
• UCSF - San Francisco Gen Hosp — San Francisco, California, United States
• Conant Med Ctr — San Francisco, California, United States
• Univ of Miami School of Medicine — Miami, Florida, United States
• BioQuan Research Group — North Miami, Florida, United States
• Grady Mem Hosp — Atlanta, Georgia, United States
• Northwestern Univ — Chicago, Illinois, United States
• Infectious Disease of Indiana — Indianapolis, Indiana, United States
• Johns Hopkins Oncology — Baltimore, Maryland, United States
• Massachusetts Gen Hosp — Boston, Massachusetts, United States
• Boston Med Ctr — Boston, Massachusetts, United States
• Beth Israel Med Ctr — Boston, Massachusetts, United States
• Washington Univ School of Medicine — St Louis, Missouri, United States
• UMDNJ - New Jersey Med School — Newark, New Jersey, United States
• St Vincents Hosp / Clinical Research Program — New York, New York, United States
• New York Univ Med Ctr — New York, New York, United States
• Mem Sloan - Kettering Cancer Ctr — New York, New York, United States
• Columbia-Presbyterian Hosp — New York, New York, United States
• Albert Einstein Comprehensive Ctr — The Bronx, New York, United States
• Case Western Reserve Univ — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.